CA2001359A1 - Methode de traitement et de prevention de la pneumonie a pneumocystis carinii et d'autres maladies et formules utilisees dans cette methode - Google Patents

Methode de traitement et de prevention de la pneumonie a pneumocystis carinii et d'autres maladies et formules utilisees dans cette methode

Info

Publication number
CA2001359A1
CA2001359A1 CA2001359A CA2001359A CA2001359A1 CA 2001359 A1 CA2001359 A1 CA 2001359A1 CA 2001359 A CA2001359 A CA 2001359A CA 2001359 A CA2001359 A CA 2001359A CA 2001359 A1 CA2001359 A1 CA 2001359A1
Authority
CA
Canada
Prior art keywords
methods
treatment
compounds
prophylaxis
formulations
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
CA2001359A
Other languages
English (en)
Other versions
CA2001359C (fr
Inventor
Richard R. Tidwell
J. Dieter Geratz
James Edwin Hall
Dennis E. Kyle
Max Grogl
Kwasi A. Ohemeng
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
University of North Carolina at Chapel Hill
US Department of Army
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US07/262,324 external-priority patent/US4963589A/en
Priority claimed from US07/262,535 external-priority patent/US4933347A/en
Priority claimed from US07/334,730 external-priority patent/US5202320A/en
Application filed by Individual filed Critical Individual
Publication of CA2001359A1 publication Critical patent/CA2001359A1/fr
Application granted granted Critical
Publication of CA2001359C publication Critical patent/CA2001359C/fr
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/20—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D239/22—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms directly attached to ring carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/10—Anthelmintics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C257/00—Compounds containing carboxyl groups, the doubly-bound oxygen atom of a carboxyl group being replaced by a doubly-bound nitrogen atom, this nitrogen atom not being further bound to an oxygen atom, e.g. imino-ethers, amidines
    • C07C257/10—Compounds containing carboxyl groups, the doubly-bound oxygen atom of a carboxyl group being replaced by a doubly-bound nitrogen atom, this nitrogen atom not being further bound to an oxygen atom, e.g. imino-ethers, amidines with replacement of the other oxygen atom of the carboxyl group by nitrogen atoms, e.g. amidines
    • C07C257/18—Compounds containing carboxyl groups, the doubly-bound oxygen atom of a carboxyl group being replaced by a doubly-bound nitrogen atom, this nitrogen atom not being further bound to an oxygen atom, e.g. imino-ethers, amidines with replacement of the other oxygen atom of the carboxyl group by nitrogen atoms, e.g. amidines having carbon atoms of amidino groups bound to carbon atoms of six-membered aromatic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Pulmonology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
CA002001359A 1988-10-25 1989-10-24 Methode de traitement et de prevention de la pneumonie a pneumocystis carinii et d'autres maladies et formules utilisees dans cette methode Expired - Fee Related CA2001359C (fr)

Applications Claiming Priority (8)

Application Number Priority Date Filing Date Title
US07/262,324 US4963589A (en) 1988-10-25 1988-10-25 Methods for treating Giardia lamblia
US07/262,535 US4933347A (en) 1988-10-25 1988-10-25 Diamidines and bis(imidazolines) for the treatment of and prophylaxis against pneumocystis carinii pneumonia
US262,324 1988-10-25
US262,535 1988-10-25
US33459089A 1989-04-06 1989-04-06
US07/334,730 US5202320A (en) 1989-04-06 1989-04-06 Method for treating leishmaniasis
US334,590 1989-04-06
US334,730 1989-04-06

Publications (2)

Publication Number Publication Date
CA2001359A1 true CA2001359A1 (fr) 1990-04-25
CA2001359C CA2001359C (fr) 1997-05-06

Family

ID=27500733

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002001359A Expired - Fee Related CA2001359C (fr) 1988-10-25 1989-10-24 Methode de traitement et de prevention de la pneumonie a pneumocystis carinii et d'autres maladies et formules utilisees dans cette methode

Country Status (13)

Country Link
EP (1) EP0366066B1 (fr)
JP (1) JP2887397B2 (fr)
AR (1) AR248011A1 (fr)
AT (1) ATE119147T1 (fr)
AU (1) AU626033B2 (fr)
BR (1) BR8905441A (fr)
CA (1) CA2001359C (fr)
CH (1) CH679857A5 (fr)
DE (1) DE68921413T2 (fr)
DK (1) DK526689A (fr)
FI (1) FI895039A0 (fr)
IL (1) IL92101A (fr)
NO (1) NO894222L (fr)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5246965A (en) * 1991-06-11 1993-09-21 Ciba-Geigy Arylethers, their manufacture and methods of treatment
US5488160A (en) * 1991-06-11 1996-01-30 Ciba-Geigy Corporation Amidino compounds, their manufacture and method of treatment
ATE125791T1 (de) * 1991-06-11 1995-08-15 Ciba Geigy Ag Amidino-verbindungen, ihre herstellung und verwendung als arzneimittel.
EP0518818A3 (en) * 1991-06-11 1993-04-28 Ciba-Geigy Ag Arylethers, their manufacture and use as medicament
US5451700A (en) * 1991-06-11 1995-09-19 Ciba-Geigy Corporation Amidino compounds, their manufacture and methods of treatment
WO1993016036A1 (fr) * 1992-02-05 1993-08-19 Boehringer Ingelheim Kg Nouveaux derives de l'amidine, leur fabrication et leur application en tant que medicaments ayant un effet antagoniste a ltb4
US5428051A (en) * 1992-10-13 1995-06-27 University Of North Carolina Methods of combating pneumocystis carinii pneumonia and compounds useful therefor
US5637621A (en) * 1994-11-14 1997-06-10 Nzym, Inc. Methods and compositions for treating Botrytis infections
EP0792262A2 (fr) * 1994-11-14 1997-09-03 Nzym, Inc. Methodes et compositions pour le traitement de mycoses phytopathogenes
US5629348A (en) * 1994-11-14 1997-05-13 Nzym, Inc. Methods and compositions for treating septoria infections
US5723495A (en) 1995-11-16 1998-03-03 The University Of North Carolina At Chapel Hill Benzamidoxime prodrugs as antipneumocystic agents
CA2340912C (fr) * 1998-08-20 2008-11-18 University Of North Carolina At Chapel Hill Composes de dibenzofuranne et de dibenzothiophene dicationiques et leurs procedes d'utilisation
DE19853944A1 (de) * 1998-11-24 2000-05-25 Bourdichon Alain Jacques Verwendung von Diminazen-di-aceturat zur Behandlung von Malaria
WO2005089738A2 (fr) * 2004-03-17 2005-09-29 Mpex Pharmaceuticals, Inc. Utilisation et administration d'inhibiteurs de pompe d'efflux de bacteries
RU2620016C1 (ru) * 2016-03-28 2017-05-22 Федеральное государственное бюджетное учреждение "Федеральный научный центр трансплантологии и искусственных органов имени академика В.И. Шумакова" Министерства здравоохранения Российской Федерации Способ профилактики пневмоцистной пневмонииии у реципиентов сердца в раннем послеоперационном периоде после трансплантации сердца

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2277861A (en) * 1937-12-10 1942-03-31 May & Baker Ltd Process for the preparation of diamidine derivatives
FR925999A (fr) * 1945-03-22 1947-09-18 May & Baker Ltd Procédé de préparation d'amidines

Also Published As

Publication number Publication date
FI895039A0 (fi) 1989-10-24
DK526689A (da) 1990-04-26
BR8905441A (pt) 1990-10-23
ATE119147T1 (de) 1995-03-15
DE68921413T2 (de) 1995-06-29
DK526689D0 (da) 1989-10-24
JP2887397B2 (ja) 1999-04-26
NO894222L (no) 1990-04-26
EP0366066A1 (fr) 1990-05-02
NO894222D0 (no) 1989-10-24
AU626033B2 (en) 1992-07-23
JPH02243666A (ja) 1990-09-27
EP0366066B1 (fr) 1995-03-01
CA2001359C (fr) 1997-05-06
IL92101A (en) 1995-11-27
CH679857A5 (fr) 1992-04-30
AU4366789A (en) 1990-05-03
AR248011A1 (es) 1995-05-31
DE68921413D1 (de) 1995-04-06

Similar Documents

Publication Publication Date Title
CA2001359A1 (fr) Methode de traitement et de prevention de la pneumonie a pneumocystis carinii et d'autres maladies et formules utilisees dans cette methode
PT84964A (en) Process for the preparation of 1,5-diaryl-3-substituted-pyrazoles and of pharmaceutical compositions containing them
AU693747B2 (en) Imidazo(4,5-c)pyridin-4-amines
CA2152615A1 (fr) Compositions pharmaceutiques a base d'atovaquone
CA2163361A1 (fr) Derives de substitution de guanidines, agents therapeutiques
MX18106A (es) Compuesto amidinicos y composiciones usadas para el tratamiento de pneumonia por pneumocystis carinii y otras enfermedades.
GR3007385T3 (fr)
GR1002486B (el) Νεα κρυσταλλικη μορφη κυκλοσπορινης, μεθοδος παραγωγης της,φαρμακευτικες συνθεσεις περιεχουσες αυτη και η χρησις της.
AU1520188A (en) Compositions and methods of treatment of timber
HUT43828A (en) Process for producing 1,1-disubstituted cyclopropan derivatives and pharmaceutical and/or fungicide compositions containing them as active agents
NZ232946A (en) Preparation of crystalline 17alpha-hydroxy-7alpha methyl-19-nor-17-pregn-5
NZ222758A (en) Cosmetics and pharmaceutical compositions from cereal plants
PT85483A (en) Process for the preparation of novel 1,4-dihydropyridine derivatives with calcium agonist and alpha 1-antagonist activity and of pharmaceutical compositions containing the same
AU2447688A (en) Pentamidine salts useful in the treatment and prophylaxis of pneumocystis carinii pneumonia
MD1360C2 (ro) Compoziţie fungicidă, procedeu de combatere şi prevenire a infectării cu Oomicete a plantelor
CA2063273A1 (fr) Surfactants pulmonaires et methodes
HUT45000A (en) Fungicide compositions containing terciery amines as active components and process for producing the active components
CA2139652A1 (fr) Inhibiteurs de la thrombine
HUT43829A (en) Process for producing 1,1-disubstituted cyclopropan derivatives and pharmaceutical and/or fungicide compositions containing them as active agents
NZ230356A (en) 2',3'-dideoxy-5-ethynyl-3'-fluorouridine: preparatory processes and pharmaceutical compositions
GR870518B (en) Herbicide compositions based on biscarbamate and method of herbicide treatment using said compositions
CA2047802A1 (fr) Compositions pharmaceutiques
ZA91115B (en) Topical compositions
AU3108289A (en) Compositions comprising 24,25-dihydroxy-vitamin D3 and calcium for the treatment of osteoporosis in humans
CA2075926A1 (fr) Esters d'acides amines et d'hydroquinone, methodes d'obtention et compositions phramaceutiques ou cosmetiques qui en contiennent

Legal Events

Date Code Title Description
EEER Examination request
MKLA Lapsed